Back

Role of new oral anticoagulants in left atrial occluder device implants

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation III Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Zulkeflee Muhammad

National Heart Institute, Kuala Lumpur (Malaysia)

24 More presentations in this session

Presentation thumbnail
Professor D. Xavier (Bangalore, IN)
Abstract Slides
Presentation thumbnail
Doctor C. Gatti (Ravenna, IT)
Abstract Slides
Presentation thumbnail
Doctor D. Iglesias (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Doctor J. Wieczorek (Katowice, PL)
Abstract Slides
Presentation thumbnail
Associate Professor A. Parwani (Berlin, DE)

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation III

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial appendage closure in atrial fibrillation: gaps in knowledge
1 September 2025
thumbnail
Congress Presentation
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
2 September 2019
thumbnail
Webinar
Are NOACs already outdated? New trends in anticoagulation therapy
12 December 2022
thumbnail
Congress Presentation
Is warfarin associated with higher risk of thrombus in left atrial appendage than direct oral anticoagulants?
11 December 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources